Intraoperative Contrast-Enhanced Ultrasonography (Io-CEUS) in Minimally Invasive Thoracic Surgery for Characterization of Pulmonary Tumours: A Clinical Feasibility Study.
Io-CEUS
contrast-enhanced ultrasound
intraoperative ultrasound
pulmonary tumour
thoracic surgery
Journal
Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829
Informations de publication
Date de publication:
29 Jul 2023
29 Jul 2023
Historique:
received:
26
06
2023
revised:
19
07
2023
accepted:
27
07
2023
medline:
12
8
2023
pubmed:
12
8
2023
entrez:
12
8
2023
Statut:
epublish
Résumé
The intraoperative detection of solitary pulmonary nodules (SPNs) continues to be a major challenge, especially in minimally invasive video-assisted thoracic surgery (VATS). The location, size, and intraoperative frozen section result of SPNs are decisive regarding the extent of lung resection. This feasibility study investigates the technical applicability of intraoperative contrast-enhanced ultrasonography (Io-CEUS) in minimally invasive thoracic surgery. In this prospective, monocentric clinical feasibility study, n = 30 patients who underwent Io-CEUS during elective minimally invasive lung resection for SPNs between October 2021 and February 2023. The primary endpoint was the technical feasibility of Io-CEUS during VATS. Secondary endpoints were defined as the detection and characterization of SPNs. In all patients (female, n = 13; mean age, 63 ± 8.6 years) Io-CEUS could be performed without problems during VATS. All SPNs were detected by Io-CEUS (100%). SPNs had a mean size of 2.2 cm (0.5-4.5 cm) and a mean distance to the lung surface of 2.0 cm (0-6.4 cm). B-mode, colour-coded Doppler sonography, and contrast-enhanced ultrasound were used to characterize all tumours intraoperatively. Significant differences were found, especially in vascularization as well as in contrast agent behaviour, depending on the tumour entity. After successful lung resection, a pathologic examination confirmed the presence of lung carcinomas (n = 17), lung metastases (n = 10), and benign lung tumours (n = 3). The technical feasibility of Io-CEUS was confirmed in VATS before resection regarding the detection of suspicious SPNs. In particular, the use of Doppler sonography and contrast agent kinetics revealed intraoperative specific aspects depending on the tumour entity. Further studies on Io-CEUS and the application of an endoscopic probe for VATS will follow.
Sections du résumé
BACKGROUND
BACKGROUND
The intraoperative detection of solitary pulmonary nodules (SPNs) continues to be a major challenge, especially in minimally invasive video-assisted thoracic surgery (VATS). The location, size, and intraoperative frozen section result of SPNs are decisive regarding the extent of lung resection. This feasibility study investigates the technical applicability of intraoperative contrast-enhanced ultrasonography (Io-CEUS) in minimally invasive thoracic surgery.
METHODS
METHODS
In this prospective, monocentric clinical feasibility study, n = 30 patients who underwent Io-CEUS during elective minimally invasive lung resection for SPNs between October 2021 and February 2023. The primary endpoint was the technical feasibility of Io-CEUS during VATS. Secondary endpoints were defined as the detection and characterization of SPNs.
RESULTS
RESULTS
In all patients (female, n = 13; mean age, 63 ± 8.6 years) Io-CEUS could be performed without problems during VATS. All SPNs were detected by Io-CEUS (100%). SPNs had a mean size of 2.2 cm (0.5-4.5 cm) and a mean distance to the lung surface of 2.0 cm (0-6.4 cm). B-mode, colour-coded Doppler sonography, and contrast-enhanced ultrasound were used to characterize all tumours intraoperatively. Significant differences were found, especially in vascularization as well as in contrast agent behaviour, depending on the tumour entity. After successful lung resection, a pathologic examination confirmed the presence of lung carcinomas (n = 17), lung metastases (n = 10), and benign lung tumours (n = 3).
CONCLUSIONS
CONCLUSIONS
The technical feasibility of Io-CEUS was confirmed in VATS before resection regarding the detection of suspicious SPNs. In particular, the use of Doppler sonography and contrast agent kinetics revealed intraoperative specific aspects depending on the tumour entity. Further studies on Io-CEUS and the application of an endoscopic probe for VATS will follow.
Identifiants
pubmed: 37568670
pii: cancers15153854
doi: 10.3390/cancers15153854
pmc: PMC10417103
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Hepatol Res. 2013 Aug;43(8):809-19
pubmed: 23745715
Ultrasound Int Open. 2018 Jan;4(1):E2-E15
pubmed: 29423461
AORN J. 2015 Jul;102(1):40-9
pubmed: 26119608
Radiologe. 2021 Dec;61(Suppl 1):19-28
pubmed: 34378067
J Thorac Dis. 2021 Feb;13(2):762-767
pubmed: 33717548
Thorac Cancer. 2020 May;11(5):1354-1360
pubmed: 32180358
Ultraschall Med. 2020 Oct;41(5):562-585
pubmed: 32707595
J Thorac Cardiovasc Surg. 2012 Nov;144(5):1160-5
pubmed: 22980667
Rofo. 2017 May;189(5):431-440
pubmed: 28449169
J Laparoendosc Adv Surg Tech A. 2003 Dec;13(6):371-5
pubmed: 14733700
Interact Cardiovasc Thorac Surg. 2015 Oct;21(4):409-14
pubmed: 26117843
Eur J Cardiothorac Surg. 2016 Feb;49(2):690-7
pubmed: 25855597
Ultrasonography. 2015 Oct;34(4):246-57
pubmed: 25971896
Can J Surg. 2015 Oct;58(5):318-22
pubmed: 26384146
J Clin Med. 2021 Sep 30;10(19):
pubmed: 34640574
J Ultrasound Med. 2021 Aug;40(8):1613-1625
pubmed: 33124700
Eur Radiol. 2003 Oct;13(10):2358-64
pubmed: 12736756
Lancet Respir Med. 2020 Mar;8(3):236
pubmed: 32035508
Clin Hemorheol Microcirc. 2012;50(1-2):65-77
pubmed: 22538536
Eur J Cardiothorac Surg. 2004 Sep;26(3):469-73
pubmed: 15302036
Cancers (Basel). 2022 Sep 29;14(19):
pubmed: 36230668
Thorac Surg Clin. 2014 May;24(2):157-62, vi
pubmed: 24780419
Ultrasound Med Biol. 2020 Dec;46(12):3483-3484
pubmed: 32888748
Abdom Radiol (NY). 2021 Aug;46(8):3579-3595
pubmed: 33825927
Interact Cardiovasc Thorac Surg. 2012 Aug;15(2):266-72
pubmed: 22572410
Clin Hemorheol Microcirc. 2010;46(2-3):89-99
pubmed: 21135485
Ultraschall Med. 2014 Dec;35(6):500-11; quiz 512-3
pubmed: 25474100
Clin Hemorheol Microcirc. 2021;78(1):103-116
pubmed: 33554890
Med Ultrason. 2017 Nov 29;19(4):374-379
pubmed: 29197913
J Gastrointest Surg. 2021 Dec;25(12):3160-3169
pubmed: 34159555
J Thorac Cardiovasc Surg. 2009 Oct;138(4):837-42
pubmed: 19660350
Clin Hemorheol Microcirc. 2016;64(4):735-745
pubmed: 27767982
Diagnostics (Basel). 2021 Sep 16;11(9):
pubmed: 34574032